Literature DB >> 10098990

Risk factors of hepatitis C virus infection in patients on hemodialysis: a multivariate analysis based on a dialysis register in Central Italy.

D Di Lallo1, M Miceli, N Petrosillo, C A Perucci, M Moscatelli.   

Abstract

A seroprevalence survey of antibodies to HCV was carried out among 2788 hemodialysis (HD) patients in a region of central Italy. Anti-HCV seroprevalence was 28.6%. A multivariate analysis of risk factors showed a significant association with time on HD, history of blood transfusion and metropolitan area of residence. Our study clearly showed that HCV infection is common among HD patients and is partially associated with preventable factors.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10098990     DOI： 10.1023/a:1007592912010

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


  16 in total

1.  Prevalence of anti-HCV in subjects of various age groups.

Authors:  A Albano; A Pianetti; M R Biffi; F Bruscolini; W Baffone; V Albano; A Salvaggio
Journal:  Eur J Epidemiol       Date:  1992-03       Impact factor: 8.082

2.  Hepatitis C virus infection among chronic dialysis patients in the southeast of France. Provence-Alpes-Côte d'Azur Nephrologists Group.

Authors:  B Dussol; P Berthezène; P Brunet; Y Berland
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

3.  Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment.

Authors:  T Allander; C Medin; S H Jacobson; L Grillner; M A Persson
Journal:  J Med Virol       Date:  1994-08       Impact factor: 2.327

Review 4.  The detection, transmission, and outcome of hepatitis C virus infection.

Authors:  M J Alter
Journal:  Infect Agents Dis       Date:  1993-06

5.  Prevalence of antibody to hepatitis C virus in hemodialysis patients.

Authors:  J Hayashi; K Nakashima; W Kajiyama; A Noguchi; M Morofuji; Y Maeda; S Kashiwagi
Journal:  Am J Epidemiol       Date:  1991-09-15       Impact factor: 4.897

6.  The risks of occupational exposure and infection by human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in the dialysis setting. Italian Multicenter Study on Nosocomial and Occupational Risk of Infections in Dialysis.

Authors:  N Petrosillo; V Puro; J Jagger; G Ippolito
Journal:  Am J Infect Control       Date:  1995-10       Impact factor: 2.918

7.  The declining risk of post-transfusion hepatitis C virus infection.

Authors:  J G Donahue; A Muñoz; P M Ness; D E Brown; D H Yawn; H A McAllister; B A Reitz; K E Nelson
Journal:  N Engl J Med       Date:  1992-08-06       Impact factor: 91.245

Review 8.  End-stage renal disease: magnitude of the problem, prognosis of future trends and possible solutions.

Authors:  F K Port
Journal:  Kidney Int Suppl       Date:  1995-08       Impact factor: 10.545

Review 9.  Hepatitis C virus: the nephrologist's view.

Authors:  D Roth
Journal:  Am J Kidney Dis       Date:  1995-01       Impact factor: 8.860

10.  Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for environmental transmission.

Authors:  M Cendoroglo Neto; S A Draibe; A E Silva; M L Ferraz; C Granato; C A Pereira; R C Sesso; A M Gaspar; H Ajzen
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992
View more
  4 in total

1.  Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment.

Authors:  Haldun Selcuk; Mehmet Kanbay; Murat Korkmaz; Gurden Gur; Ali Akcay; Hande Arslan; Nurhan Ozdemir; Ugur Yilmaz; Sedat Boyacioglu
Journal:  Dig Dis Sci       Date:  2006-07-26       Impact factor: 3.199

2.  Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients.

Authors:  H Hinrichsen; G Leimenstoll; G Stegen; H Schrader; U R Fölsch; W E Schmidt
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

3.  Epidemiology of hepatitis C virus antibodies in blood donors from the province of Latina, Italy.

Authors:  G La Torre; E De Vito; E Langiano; P Petta; G Colarossi; L Cipriani; M Tucciarone; G Ricciardi
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

4.  The role of hemodialysis machines dedication in reducing Hepatitis C transmission in the dialysis setting in Iran: a multicenter prospective interventional study.

Authors:  Alireza Abdollah Shamshirsaz; Mohammad Kamgar; Mir Reza Bekheirnia; Farzam Ayazi; Seyed Reza Hashemi; Navid Bouzari; Mohammad Reza Habibzadeh; Nima Pourzahedgilani; Varshasb Broumand; Amir Hooshang Abdollah Shamshirsaz; Maziyar Moradi; Mehrdad Borghei; Niloofar Nobakht Haghighi; Behrooz Broumand
Journal:  BMC Nephrol       Date:  2004-10-07       Impact factor: 2.388
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.